The NIH AIDS Study Sections are being reorganized to align the AIDS and Related Research (AARR) integrated review group (IRG) with current and emerging areas of HIV/AIDS research and to support best practices for scientific breadth and meeting management.
Six new study sections will cover basic, translational, clinical, and population science. The new study sections are expected to be in place in time for the September 2018 application due date.
For full details, including descriptions of the new study sections and guidance on timelines, please visit this URL:https://bit.ly/2jobWf9
Michael Bouvet, MD, the UC San Diego Moores Cancer Center, and the local Committee of the American Cancer Society Institutional Research Grant (ACS-IRG #15-172-45) are pleased to announce the availability of seed money to stimulate cancer research projects of high merit among junior investigators at UCSD.
Amount: Up to $30,000 per award (up to 6 awards; 1 year)
Deadline: 5:00PM, September 17, 2018
The ACS award is not intended to support faculty salaries, supplement existing research contracts or grants, or to be utilized as bridge funding pending renewal support of projects. Funds cannot be used for foreign travel. See online guidelines for additional formatting and budget instructions.
Awardees will be required to submit a progress report at the end of the project period, and provide updates for the ACS-IRG grant renewal. Publications resulting from awards must acknowledge “Supported by IRG Grant #15-172-45 of the American Cancer Society.”
Click here for more information
Please save the dates of Wednesday October 10th – Friday October 12th, 2018 for the fourth biennial Strategies for an HIV Cure meeting at the NIH main campus. This is a National Institute of Allergy and Infectious Diseases (NIAID) program-driven meeting with the goal of fostering communication and collaboration among researchers funded by NIAID HIV cure-related programs and grants and with the community at large. The meeting also serves as the venue for this year’s annual joint meeting of the Martin Delaney Collaboratories.
Poster abstracts are highly encouraged, oral presentations will be by invitation only. The meeting is open to the public, and registration is free.
The website for the 2018 meeting, which will provide further details on the agenda and meeting logistics, is still under development. For more information on the previous meeting in 2016, please see https://respond.niaid.nih.gov/conferences/hivcuremeeting2016. For questions, please contact NIAIDHIVCureMeeting@niaid.nih.gov
The 4th International Workshop on the Microbiome in HIV will be held 16-17 October 2018, in Rockville, MD.
The understanding of the human microbiome continues to grow rapidly; however information on the role of HIV infection on changes in the microbiome, and the role of the microbiome in HIV transmission, prevention, pathogenesis and treatment is still limited. While research in this area may be presented at major conferences, there is often limited time for in-depth discussion and debate among cross-disciplinary experts on new data and their implications. The aim of this workshop is to provide increased opportunities for discussion and exchange of knowledge following formal presentation of the latest research.
This 2 day event will have invited lectures by key research leaders from both the broader Microbiome field, as well as HIV/Microbiome investigators, oral abstract presentations and poster presentations. The conference will be unique in its approach, as it will engage basic scientists and clinicians from the HIV field and leading scientists involved in microbiome researchs. Registration is free. There will also be a Young Investigator Scholarship program to support travel, to encourage participation of emerging investigators.
More information about the program including the speakers is found here
RFA-CA-18-018 “Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)”
The Application Due Date is November 15, 2018 and the Letter of Intent (optional) due date is October 15, 2018.
Join us for a wonderful educational and inspirational event. In addition to an inspiring keynote speaker, there will be 10 educational workshops provided throughout the day. Come network and meet service providers and vendors at the Resource Fair.
October 24, 2018 at 7:30am - 4:30pm
Marina Village Conference Center
1936 Quivira Way, San Diego, CA 92109
Keynote Speaker: Shea Freedom
Learn more and register here
The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally.
The HVTN Investigators Meeting will be held in Seattle, Washington
NOVEMBER 6-7, 2018
The Grand Hyatt Hotel
721 Pine Street
Seattle, Washington, USA 98101
Phone: +1 (206) 774-1234
Fax: +1 (206) 774-6120
Note: Deadline for guest room rate is October 3, 2018.
The 2018 CFAR HIV Research Day will be held on Thursday, December 6, 2018 in the Medical Education and Telemedicine Building. Last year, more than 100 participants heard a dozen presentations on disparities in HIV prevention, treatment, and care. Learn more about this exciting one-day event! Also check the HIV Institute Facebook, Twitter, and Instagram feeds for updates.
Call for Abstracts!
If you are interested in submitting an abstract for Research Day, download the Call for Abstracts! to see the submission guidelines!
New in 2018: Emerging Investigator Prize! The best abstract by an emerging investigator will be scheduled for a 30-minute talk and the author will receive a $200 gift certificate to the UC San Diego Bookstore!
The PEER program is an international grants program that is made possible by a Cooperative Agreement between USAID and The National Academies of Sciences, Engineering, and Medicine. It is a 10-year program with a $100 million ceiling and was designed to support collaboration between foreign scientists and United States Government researchers. PEER-eligible countries may be found in the accompanying slides, along with examples of PEER projects with NIH partners.
The PEER Model invites local, in-country scientists to propose a research project that aligns with U. S. congressional priorities and country interests. Additional DC-based core funds are available to support projects deemed meritorious but are not necessarily aligned with the outlined research goals.
The 2018/2019 (Cycle 8) announcement will likely be the last call for projects. The solicitation and goals for Cycle 8 will be announced in the Fall on the PEER website. Pre-proposals will be due to the National Academies around mid-January and selected applicants will be invited to submit a full proposal, which will be due in the beginning of April. More information on the application process may be found here.
Those with questions regarding the program are encouraged to visit the program’s FAQ page.
More info: General PEER Slides 2018
The AFP for Prevention Symposium will be held on January 28-29, 2019. The location of the symposium will be at the Emory Conference Center in Atlanta, GA.
Stay tuned for more details about the symposium.
Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
Due date: January 8, 2019, by 5:00 PM
Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
Due date: January 8, 2019, by 5:00 PM
Here are the following grants:
Read more about it here!
We are proud to announce that Jamila K. Stockman, PhD, MPH (front row, second from right), was honored at the YWCA of San Diego County’s 20th Annual In the Company of Women benefit luncheon, featuring the distinguished Tribute to Women & Industry Awards (TWIN) on Friday, May 4, 2018. These prestigious awards celebrate the strength, courage, and spirit of women and their extraordinary achievements. This year’s TWIN Award acknowledges Dr. Stockman’s leadership and research career, which is dedicated to improving the lives of women who have experienced intimate partner and sexual violence. Her research is advancing our understanding and providing interventions to reduce HIV, substance abuse, and violence against women. In addition to her research, Dr. Stockman actively collaborates with local public health departments and community-based organizations to address the negative effects of violence and HIV in families and relationships. Dr. Stockman is Vice Chief and Associate Professor in the Division of Infectious Diseases and Global Public Health, and Director of the Disparities Core, San Diego Center for AIDS Research. Congratulations on this notable and deserving award!
We are proud to announce that Dr. Brooke West, PhD recieved the IAS Injecting Drug Use Research Prize at the 2018 22nd International AIDS Conference in Amsterdam. Dr. West is an Assistant Professor in the Division of Infectious Diseases and Global Public Health at UCSD.
The three IAS Injecting Drug Use Research Prizes are awarded by the IAS HIV Co-Infections and Co-Morbidities initiative. They are incentives for researchers to address important research questions around the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, in particular through interdisciplinary research on drug dependence, harm reduction and/or drug policy. The prizes are presented to the three top-scoring abstracts in any of these areas.
Dr. Jill Blumenthal will be speaking on Thursday, February 22, beginning at 2:00 p.m. in CRSF 228 a/b.
Dr. Blumenthal will discuss "Pre-explosure prophylaxis and women: a domestic and local perspective."
Description: This webinar will review the state of PrEP for adolescents including regulatory issues, the ATN pipeline, topics funded under the recent RFP, and existing gaps in the field.
Speaker: Sybil Hosek, PhD - Clinical Psychologist/HIV Researcher, Department of Psychiatry at Stroger Hospital of Cook County
Discussant: Lisa B. Hightow-Weidman, MD, MPH - Associate Professor of Medicine, Departments of Infectious Diseases and Health Behavior, University of North Carolina-Chapel Hill
This is the third installment of the NHLBI HIV/AIDS-related heart, lung, blood, and sleep (HLBS) research webinar series that serves to highlight state of the art research from experts in the field and provide a platform for disseminating pertinent NHLBI HIV/AIDS-related research announcements.
Join our next webinar that will be held on Monday, March 12th, 2018 from 12pm-1pm (EST) featuring Dr. Jasimuddin Ahamed who will present his work on HIV protease inhibitor-induced cardiovascular disease: role of platelet activation and TGF-?1. There will also be a short Q&A session to discuss upcoming NHLBI HIV/AIDS funding opportunities. To register for the webinar, you can click on the “Click Here to Register” box in the flyer below or click this link: . Once registered, an email with detailed instructions for accessing the webinar will be sent to you directly; you can access the webinar agenda via the webinar access link.
If you would like to present your research or nominate another investigator for one of these webinars, please email Leia Novak (NHLBI HIV/AIDS scientific program manager), at Leia.email@example.com. If you would like to join the NHLBI listserv through which these webinar announcements are disseminated, please click this link https://list.nih.gov/ and click on ‘search public lists’ and enter the following text ‘NHLBI-HIVRESEARCH_FOA-L’ to find the correct listserv and join.
This one-and-a-half-day public workshop will discuss infectious disease consequences of the opioid epidemic, giving particular attention to viral hepatitis, HIV, and endocarditis. The workshop will address strategies to prevent and treat infections in people who inject drugs, especially strategies that emphasize empathy, respectful treatment, and patient satisfaction. The speakers will address ways to work efficiently though the existing public health and medical systems. The agenda will be posted on the workshop webpage shortly.
When: March 12-13, 2018
Location: Washington, D.C.
Webcast: Watch here on the day(s) of the event
Adriane Wynn will be speaking on Thursday, March 22, beginning at 2:00 p.m. in CRSF 228 a/b.
Dr. Wynn will discuss "Sexually transmitted infections in pregnancy from a global perspective"
Dr. Holly B. Shakya will be speaking on Thursday, April 5th, beginning at 2:00 p.m. in CRSF 228 a/b.
Dr. Shakya will discuss "Social network analysis as an innovative method to identify reference groups for social norms: a practice job talk"
You are invited to the UC San Diego Altman Clinical and Translational Research Institute (ACTRI) Translational Science Symposium: “Emerging Issues and Solutions in Infectious Disease,” scheduled from 2:30 – 5:30 p.m. on Thursday, April 5, 2018, in the ACTRI Building. The symposium is free, but there is limited seating and registration is required. Presentations are geared for researchers, but open to campus members and ACTRI partners. Please contact Patti Weiser (firstname.lastname@example.org) at the ACTRI if you have questions.
The keynote speaker is former FDA Commissioner Robert Califf, MD, a nationally and internationally recognized expert in cardiovascular medicine and former vice chancellor of clinical and translational research at Duke University.
The symposium will also feature mini-presentations by researchers supported by ACTRI and the presentation of the 2018 Daniel T. O’Connor Memorial Award. The event will run from 2:30 p.m. to 5:30 p.m. at the ACTRI building. It is free, but there is limited seating and registration is required. Presentations are geared for researchers, but open to campus members and ACTRI partners.
Division of Infectious Diseases and Global Public Health
Aaron Carlin and Gabriel Wagner, Division of Infectious Diseases and Global Public Health, are two of the presenters.
Date/Time: Tuesday, April 10th, 2018; 12:00pm-1:00pm (EST)
Speaker: Christopher Longenecker, MD; Assistant Professor of Medicine, Case Western Reserve University
Title: Epidemiology and Mechanisms of Cardiovascular Disease among People Living with HIV in Sub-Saharan Africa
Registration Link: goo.gl/ZAz5vs
The first annual HIV Mucosal Systems Meeting (April 29th -May 2nd 2018, Santa Rosa, CA) abstract deadline is this Friday February 23rd by 8pm EST. Please submit abstracts to email@example.com. The goal of this meeting is to provide a much-needed platform for international interchange on important topics relating to HIV interactions with mucosal systems. Sessions include: an overview session describing HIV relevant mucosal, mucosal innate and adaptive immunology, mucosal epithelial barriers, microbiome, mucous properties, mucosal transmission, interventions, technological advancements in mucosal research, and relevant epidemiology and clinical science aspects in HIV.
Please limit your abstract body to 300 words, and designate if you are an early career investigator eligible for a scholarship (defined here as in a training position such as graduate student, postdoctoral fellow, or within 3 years of Assistant Professor designation). Scholarships will be awarded based on abstract quality and will cover registration and lodging costs for 20+ young investigators. Notifications of abstract disposition and scholarship awards will come on or before March 12th, 2018 via email.
Registration is also now open!! Please visit:
Room blocks at $139/night are being held until March 29th. As a reminder the registration fee is $300 until 3/29, and $450 thereafter.
Please forward along to anyone who may be interested, and we highly encourage trainees to attend. Please email firstname.lastname@example.org with any questions or concerns.
Date/Time: Friday, May 4th, 2018; 12:00pm – 1:00pm (EST)
Speaker: Maria Jose Miguez, MD, PhD; Professor, Florida International University
Title: Platelets Should Be At The Frontline of HIV Research
Registration Link: goo.gl/HCPVS4
The African Academy of Sciences (AAS), the U.S. National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are partnering under the auspices of the Coalition of African Research & Innovation (CARI) to establish a postdoctoral training fellowship program, the African Postdoctoral Training Initiative (APTI). Training will be at a world class institute, the intramural laboratories of NIH.
APTI fellows will train in a global health research area of priority for their home institutions and countries, and AAS, BMGF and NIH, while building bridges and lasting connections between the partner organizations and African scientists and institutions. While at the NIH, the fellows must be on leave or sabbatical from their home institution under the NIH Intramural Visiting Fellow Program (https://policymanual.nih.gov/2300-320-3). The research priority areas are in infectious diseases, nutrition, and reproductive, maternal, and child health and developing skills for clinical and translational research. More information available
Application deadline: May 11, 2018
Final selection: June 1, 2018
APTI fellows must be prepared to begin their fellowship at NIH no later than September 30, 2018.
Link to application - will open April 11, 2018
Download the sample application form: http://www.aasciences.ac.ke/download/5ac73510b0f49/
Grants Officer, African Academy of Sciences
Phone: +254 20 240 5150. Email: email@example.com
Program Specialist, Fogarty International Center, NIH
Phone: +1-301-496-4784. Email: firstname.lastname@example.org
Program Officer, Fogarty International Center, NIH
Phone: +1-301-496-4784. Email: email@example.com
This is another opportunity that may be of interest to early-stage HIV investigators who would like an opportunity for short-term training. This proposal is not tied to the CFAR grant and is a standalone submission to CDRF but funded by OAR.
Please note the eligibility criteria as described in the RFP. Feel free to disseminate as appropriate.
Please see the attached RFP and also the website below for more information.
Program Point of Contact:
Sheila Ribeiro, CRDF Global, firstname.lastname@example.org
Date/Time: Tuesday, June 5th, 2018; from 2:00pm-3:00pm (EST)
Speaker: Xu Yu, MD; Associate Professor at Harvard Medical School
Title: Unraveling the Mechanisms of Durable Control of HIV-1
Registration Link: goo.gl/ae2qQd
The Division of AIDS Research at the National Institute of Mental Health (NIMH) has organized two pre-conference sessions the morning of Friday June 8, 2018 at the Adherence 2018 Conference in Miami, Florida.
Time: 9:00 – 10:30 am Eastern Time
Co-Chairs: Teri Senn (NIMH) and Kathy Sikkema (Duke University)
Time: 10:30 am – 12:00 pm Eastern Time
Co-Chairs: Gregory Greenwood (NIMH), Jonathon Rendina (Hunter College) and Janet Turan (University of Alabama, Birmingham)
Sessions will include presentations from investigators conducting state-of-the-science research, followed by moderated discussions focused on gaps in current research knowledge. Audience members will have a chance to ask questions and participate in the discussions.
Administrative supplements to support interdisciplinary scientific collaborations between CFAR and nursing schools and research organizations supporting nursing research! The purpose of this supplement is to support innovative research on HIV-related nursing science from early stage investigators who are affiliated with nursing schools or research organizations that support nursing research. The National Institute of Nursing Research (NINR) intends to provide supplemental funds to CFARs to help develop collaborations between nursing schools or organizations that support nursing research affiliated with or near to CFARs.
Funding will be in the form of a supplement to the Developmental Core with funds restricted for use in pilot studies to support innovative HIV-related nursing research.
NOTE: Studies involving clinical trials are not allowed.
Receipt Date: June 18, 2018
The award is intended for early stage investigators who are in the process of developing an independent research career and who have not yet received an R01 or equivalent grant from the NIH. Post-doctoral fellows are eligible if they are in their final year and transitioning to a faculty position. Applicants must have a research or health-professional doctoral degree. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for NIH support. Multiple PDs/PIs are not allowed.
More information: NINR CFAR Supplement
The Third Coast CFAR is pleased to announce two new resources for HIV researchers with an interest in Implementation Science. Over the last two years, our Behavioral, Social, and Implementation Sciences core has worked closely with colleagues in the NIDA-funded Center for Prevention Implementation Methodology (Ce-PIM) at Northwestern to develop a series of workshops tailored to faculty engaged in or interested in HIV research. On the Third Coast CFAR website, you will find embedded videos of both the 101 and 201 courses as well PDFs of the slides. http://www.thirdcoastcfar.org/implementation-science/
CE-PIM has also been hosting a series of virtual lectures on implementation science as part of the Prevention Science and Methodology Group, which can be found here: http://cepim.northwestern.edu/calendar-events?category=Implementation+Methods
Please feel free to disseminate this information through your networks. We look forward to sharing more implementation science resources across CFARs after we host the HIV implementation science workshop at the end of April supported through a CFAR supplement to Third Coast and Johns Hopkins. We will be discussing the formation of an inter-CFAR working group at the workshop.
RFA-DK-18-009, “Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)” Due Date: March 14, 2019.
PAS-18-698, “High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)” For those not familiar with this type of funding opportunity, a PAS is a Program Announcement with set-aside funds (hence, the “S” in “PAS”).
NIDDK also participates in PAR-18-189, “Multidisciplinary Studies of HIVAIDS and Aging (R01 Clinical Trial Optional) and PAR-18-190, “Multidisciplinary Studies of HIVAIDS and Aging (R21 Clinical Trial Optional). NIDDK’s interest statements are described in the Notices which are also linked to each of the PARs under “Related Notices” (NOT-DK-18-005 and NOT-DK-18-006).
Date/Time: Thursday, August 9th, 2018; from 2:00pm – 3:00pm (EST)
Speaker: Edward Murphy, MD, MPH; Professor at University of California, San Francisco
Title: Using the Blood Center as a Platform for HIV Cure Research in South Africa
Registration Link: https://goo.gl/5oM2S8
The Southeast San Diego Local Faith Community and the UC San Diego Center for AIDS Research Disparities Core cordially invites you to attend San Diego’s first Faith Community HIV/AIDS Awareness Day, which is taking place this weekend in conjunction with the National Faith HIV/AIDS Awareness Day. See attached event invitation flyer and the Facebook event page and please widely share with your organizations, faith groups, networks, colleagues, family, and friends.
While prevention and treatment of HIV/AIDS has improved in the United States, there are still many health disparities, particularly affecting our minority communities. The Jacobs Center has been a beacon of hope in Southeast San Diego, where many members of the community are in the highest at-risk group for HIV. The California HIV/AIDS Research program (CHRP), along with the University of California San Diego, and other organizations have been seeking ways to positively impact these at-risk populations. This awareness event will be led by several denominations of our local faith community and we invite the entire community.
Date/Time: Monday, September 10th, 2018; from 2:00pm – 3:00pm (EST)
Speaker: Eliseo Eugenin, PhD; Associate Professor at Rutgers University
Title: HIV Infection, Gap Junctions, and Heart Disease
Oct. 2, 2017 - CFAR AFP-WG Webinar: New NIH Funded Research to Advance Oral PrEP Use and Delivery
Description: This webinar will review current evidence on PrEP use, and then highlight a recent NIH initiative which called for research applications on “Improving the HIV PrEP Cascade” (RFAMH-17-360 and 361). The initiative sought research to help speed PrEP access and uptake, support PrEP medication adherence and care retention, and prioritize key populations and reduce disparities in PrEP use. Research awards newly underway through this initiative will pioneer work in underserved populations, test innovative approaches to improve PrEP care engagement, and address important provider and care-system factors related to PrEP use.
Presenter: Michael Stirratt, PhD - NIMH Division of AIDS Research
Discussant: Dawn Smith, MD - Centers for Disease Control and Prevention
Nov. 13, 2017 - High sensitivity testing & translational science
Description: This webinar will review HIV testing technologies, the importance of screening for acute HIV infection in PrEP programs, and the growing data on the impact of PrEP on HIV tests during seroconversion. We will review some of the translational science around PrEP and
HIV testing and discuss some of the remaining implementation science questions on the topic.
Speaker: Joanne Stekler, MD, MPH - Associate Professor, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington
Discussant: Demetre Daskalakis, MD, MPH - Deputy Commissioner for the Division of Disease Control at the New York City Department of Health and Mental Hygiene
The 2017 CFAR HIV Research Day was held on Wednesday, December 6, in the Great Hall of the International House. More than 100 participants heard a dozen presentations on disparities in HIV prevention, treatment, and care. Check out the agenda and learn more about this exciting one-day event! Also check the HIV Institute Facebook, Twitter, and Instagram feeds.
The student team, which is advised by Dr. Davey Smith, Co-Director of the UC San Diego Center for AIDS Research, has won first place in the National Academy of Engineering's Global Grand Challenges Summit business model competition! Congratulations!!!
The team recently incorporated as Worldcare Technologies, a public benefit corporation. Their goal is to take their advances all the way through clinical trials, manufacturing and distribution to make real-world impacts with the devices/technologies they are designing to monitor the effectiveness of HIV treatment in low-resource areas of the globe.
Kirk Hutchison (BS History ’18) is CEO, Worldcare Technologies. He is shown here with his team, third from the right.